Newcastle Pathology Node
To address the main challenges facing Molecular Pathology and the development of stratified medicine in the UK, the Newcastle Molecular Pathology Node will draw on the significant amount of expertise in Newcastle for research, computing and engineering to discover and develop novel molecular pathology tests and invest in training programmes for future generations of Molecular Pathologists.
Building on our strengths in discovery science there will be an emphasis on the development of in vitro diagnostics and biomarker identification for disease stratification in chronic and rare diseases.
Initial projects will focus on mitochondrial, liver and bowel disease and childhood cancer.
Specialists in bioengineering, computing and biobanking will also be brought together to investigate innovative new sensing, imaging and analytical technologies as potential new diagnostic tools, with the application of mathematical and statistical methodologies for the extraction of information from complex datasets.
Working closely with the Newcastle Diagnostic Evidence Cooperative, links with commercial partners will be established to translate research findings in to clinical applications for patients.
All activity will be linked to the development of a Master’s degree, intercalated degrees for medical students and a fellowship scheme to promote capacity building in Molecular Pathology.